CRISTINA CRANKSHAW: Open Payments
NPI 1184158255 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 19 payments from 9 companies in 2025. Trend: 2023 $656 · 2024 $723 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Radius Health, Inc. | 7 | $234 |
| Tandem Diabetes Care, Inc. | 2 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Insulet Corporation | 3 | $104 |
| Novo Nordisk Inc | 1 | $89 |
| Edwards Lifesciences Corporation | 1 | $82 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $25 |
| CeQur Corporation | 1 | $8 |
Products named: Tymlos, t:slim X2 Insulin Pump with Control-IQ, Kerendia, Omnipod, Wegovy, SAPIEN 3 Ultra RESILIA, RECORLEV, MOUNJARO.
Industry payments across CA — which companies pay providers there.
